Company News in the Life Science Industry

»

Reset 

LIDDS publishes the outcome in the Share Issues

Read more ››
By: GlobenewsWire - 09 Jul 2020
Related companies:  LIDDS AB

TELA Bio Announces Interim Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair

Read more ››
By: GlobenewsWire - 09 Jul 2020
Related companies:  Tela Bio, Inc

ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer

Read more ››
By: GlobenewsWire - 09 Jul 2020

Anteris Technologies to Host TAVR Key Opinion Leader Symposium Moderated by Matt Miksic of Credit Suisse on July 20th, 2020

Read more ››
By: GlobenewsWire - 09 Jul 2020

Eye Surgeons Celebrate Global Vision Correction Month

SCOTTSDALE, Ariz., July 9, 2020 /PRNewswire/ -- July is Global Vision Correction Month and members of the Refractive Surgery Alliance (RSA), a global professional organization of leading eye surgeons, will celebrate by sharing their own vision correction surgery to raise awareness on... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  IROC AG (Institute for Refractive and Ophthalmic Surgery)

Menarini Ricerche Announces the Latest Findings of Its Vaborem™ and Quofenix™ Clinical Studies

Findings included in the abstract book of the 30(th) European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

Read more ››
By: PR Newswire Association LLC. - 09 Jul 2020

Major Healthcare Providers in Israel Choose Sectra's Digital Pathology Solution for Full-scale Primary Diagnostics

LINKÖPING, Sweden, July 9, 2020 /PRNewswire/ -- Hadassah Medical Center and Assuta Medical Center, two of the leading healthcare providers in Israel, have decided to digitize their pathology departments with a solution from international medical imaging IT and cybersecurity company... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  Sectra AB

IRLAB's Clinical Drug Candidate IRL752 Published in JPET

STOCKHOLM, July 9, 2020 /PRNewswire/ -- IRLAB announced today that a scientific paper reporting the distinctive pharmacological profile of IRL752, in development for the treatment of impaired balance and falls in Parkinson's disease, is accepted and published online in the Journal of Pharmacology... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  IRLAB Therapeutics AB

CEBINA Identifies a Common Antihistamine Nasal Spray as a Potential Anti-COVID-19 Approach

VIENNA, July 9, 2020 /PRNewswire/ -- CEBINA GmbH, an Austrian biotech company, announces positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with activity against SARS-CoV-2 infection in in vitro assays. One of these drugs,... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020

WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia

SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ -- WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series "Collaborations That Transform," highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  WuXi AppTec Inc. | WuXi AppTec Advanced Therapies

IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor

SOUTH SAN FRANCISCO, Calif., July 9, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced First-Patient-In (FPI) in the Phase 1 combination study of IDE196 and... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  IDEAYA Biosciences, Inc.

West to Host Second-Quarter 2020 Conference Call

EXTON, Pa., July 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  West Pharmaceutical Services, Inc.

E2IP mandated by CAE to help deliver critical ventilator initiative

MONTREAL, July 9, 2020 /CNW Telbec/ - E2IP TECHNOLOGIES is proud to be one of CAE's suppliers in the manufacturing of the CAE Air1(TM) ventilator destined to be used in the fight against COVID-19 throughout Canada.

Read more ››
By: PR Newswire Association LLC. - 09 Jul 2020

Are we prepared for a COVID-19 resurgence? CMA highlights top 5 issues Canada needs to address

OTTAWA, ON, July 9, 2020 /CNW/ - Four months ago, Canada was unprepared for the first wave of the COVID-19 pandemic hitting Canadian soil but managed to flatten the curve. Last week, the head of the World Health Organization warned that flare-ups are inevitable as nations begin lifting lockdown... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020

MolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria in Wounds  in a Surgical Setting

New Disposable Sleeve allows MolecuLight i:X to Be Used in Operating Rooms (for skin grafts and skin substitutes), in Covid-19 Wards and in MRSA Isolation Wards

Read more ››
By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  MolecuLight Inc.

Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 09 Jul 2020
Related companies:  Revolution Medicines, Inc.

AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program

SEATTLE, July 9, 2020 /PRNewswire/ -- Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO) AGC Biologics... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  AGC Biologics – Heidelberg | AGC Biologics – Copenhagen | AGC Biologics

Oracle Autonomous Database Now Available in Customer Datacenters

Addresses data sovereignty, security, and performance concerns that prevent some enterprise workloads from moving to the public cloud

Read more ››
By: PR Newswire Association LLC. - 09 Jul 2020

Innovent Announces First Patient Dosed in a Phase 1b Clinical Trial of Sintilimab plus Surufatinib in Advanced Malignancies in China

SUZHOU, China, July 9, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today announced... Read more ››

By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  Innovent Biologics Co., Ltd.

Coronavirus (COVID-19) Update: Daily Roundup

SILVER SPRING, Md., July 8, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic:

Read more ››
By: PR Newswire Association LLC. - 09 Jul 2020
Related companies:  U.S. Food and Drug Administration
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies